CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-28 | Haring-Layton MarDee Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2025-01-28 | JOHNSON SABRINA MARTUCCI Chef Executive Officer | Grant or award · Employee Stock Option (right to buy) | +107,000 | 107,000 | ||
| 2024-06-05 | Grossman Jessica D. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-06-05 | Steele Robin Joan Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-06-05 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-06-05 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-06-05 | Matz Gregory W Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-03-12 | Fair John A Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +290,000 | 290,000 | ||
| 2024-03-12 | JOHNSON SABRINA MARTUCCI Chef Executive Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2024-03-12 | Haring-Layton MarDee Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +290,000 | 290,000 | ||
| 2023-06-21 | Blanchard Cheryl R Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | Grossman Jessica D. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | Steele Robin Joan Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | Ononye-Onyia Sophia Nnenna Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | Kelley Susan L. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-21 | Matz Gregory W Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-24 | JOHNSON SABRINA MARTUCCI Chef Executive Officer | Grant or award · Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2023-01-24 | Walters-Hoffert Lisa Chief Financial Officer | Grant or award · Stock Option (right to buy) | +290,000 | 290,000 | ||
| 2023-01-24 | Fair John A Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +290,000 | 290,000 |
Page 2 of 18 · 344 trades